Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurobiology of Kratom and its main alkaloid mitragynine
Farah Wahida Suhaimi, Nurul H.M. Yusoff, Rahimah Hassan, et al.
Brain Research Bulletin (2016) Vol. 126, pp. 29-40
Closed Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse
Andrew C. Kruegel, Oliver Grundmann
Neuropharmacology (2017) Vol. 134, pp. 108-120
Closed Access | Times Cited: 187
7-Hydroxymitragynine Is an Active Metabolite of Mitragynine and a Key Mediator of Its Analgesic Effects
Andrew C. Kruegel, Rajendra Uprety, Steven G. Grinnell, et al.
ACS Central Science (2019) Vol. 5, Iss. 6, pp. 992-1001
Open Access | Times Cited: 160
Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program
Kirsten E. Smith, Thomas Lawson
Drug and Alcohol Dependence (2017) Vol. 180, pp. 340-348
Closed Access | Times Cited: 116
An insight review on the neuropharmacological effects, mechanisms of action, pharmacokinetics and toxicity of mitragynine
Nur Aisyah Khairul Annuar, Ummi Kalthum Azlan, Ahmed Mediani, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116134-116134
Open Access | Times Cited: 9
Kratom Withdrawal: A Systematic Review with Case Series
Cornel N. Stanciu, Samantha A. Gnanasegaram, Saeed Ahmed, et al.
Journal of Psychoactive Drugs (2019) Vol. 51, Iss. 1, pp. 12-18
Closed Access | Times Cited: 64
G protein‐biased kratom‐alkaloids and synthetic carfentanil‐amide opioids as potential treatments for alcohol use disorder
Anna M. Gutridge, Meridith T. Robins, Robert J. Cassell, et al.
British Journal of Pharmacology (2019) Vol. 177, Iss. 7, pp. 1497-1513
Open Access | Times Cited: 64
Biochemical Benefits, Diagnosis, and Clinical Risks Evaluation of Kratom
Dimy Fluyau, Neelambika Revadigar
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 60
Evaluating the hematological and clinical-chemistry parameters of kratom (Mitragyna speciosa) users in Malaysia
Darshan Singh, Christian P. Müller, Vikneswaran Murugaiyah, et al.
Journal of Ethnopharmacology (2017) Vol. 214, pp. 197-206
Closed Access | Times Cited: 59
Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs
Zurina Hassan, Oliver G. Bosch, Darshan Singh, et al.
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 52
Herbal Highs: Review on Psychoactive Effects and Neuropharmacology
Silvia Graziano, Laura Orsolini, Maria Concetta Rotolo, et al.
Current Neuropharmacology (2016) Vol. 15, Iss. 5
Open Access | Times Cited: 50
Opioid receptors mediate the acquisition, but not the expression of mitragynine-induced conditioned place preference in rats
Nurul H.M. Yusoff, Sharif Mahsufi Mansor, Christian P. Müller, et al.
Behavioural Brain Research (2017) Vol. 332, pp. 1-6
Closed Access | Times Cited: 49
Evaluation of the Mitragynine Content, Levels of Toxic Metals and the Presence of Microbes in Kratom Products Purchased in the Western Suburbs of Chicago
Walter C. Prozialeck, Joshua R. Edwards, Peter C. Lamar, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 15, pp. 5512-5512
Open Access | Times Cited: 40
Pharmacokinetics of mitragynine, a major analgesic alkaloid in kratom (Mitragyna speciosa): A systematic review
Kimheang Ya, Wimonchat Tangamornsuksan, C. Norman Scholfield, et al.
Asian Journal of Psychiatry (2019) Vol. 43, pp. 73-82
Closed Access | Times Cited: 42
Natural product modulators of human sensations and mood: molecular mechanisms and therapeutic potential
Tomáš Pluskal, Jing‐Ke Weng
Chemical Society Reviews (2017) Vol. 47, Iss. 5, pp. 1592-1637
Closed Access | Times Cited: 40
Mitragynine (Kratom) impairs spatial learning and hippocampal synaptic transmission in rats
Zurina Hassan, Farah Wahida Suhaimi, Surash Ramanathan, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 7, pp. 908-918
Open Access | Times Cited: 40
Rate and extent of mitragynine and 7‐hydroxymitragynine blood–brain barrier transport and their intra‐brain distribution: the missing link in pharmacodynamic studies
Siti R. Yusof, Mahathir Mohd Uzid, Eng‐Huat Teh, et al.
Addiction Biology (2018) Vol. 24, Iss. 5, pp. 935-945
Closed Access | Times Cited: 38
Kratom instrumentalization for severe pain self-treatment resulting in addiction – A case report of acute and chronic subjective effects
Elisabeth Müller, Thomas Hillemacher, Christian P. Müller
Heliyon (2020) Vol. 6, Iss. 7, pp. e04507-e04507
Open Access | Times Cited: 33
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Human Psychopharmacology Clinical and Experimental (2021) Vol. 37, Iss. 1
Open Access | Times Cited: 32
Recent Advances in the Anti-Inflammatory Activity of Plant-Derived Alkaloid Rhynchophylline in Neurological and Cardiovascular Diseases
Rajeswari Gopal Geetha, Surya Ramachandran
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1170-1170
Open Access | Times Cited: 30
Psychoactive Substances of Natural Origin: Toxicological Aspects, Therapeutic Properties and Analysis in Biological Samples
Joana Gonçalves, Ângelo Luís, Eugénia Gallardo, et al.
Molecules (2021) Vol. 26, Iss. 5, pp. 1397-1397
Open Access | Times Cited: 27
Mitragynine (Kratom)—Withdrawal behaviour and cognitive impairments can be ameliorated by an epigenetic mechanism
Suleiman Yunusa, Christian P. Müller, Zurina Hassan
British Journal of Pharmacology (2024) Vol. 181, Iss. 13, pp. 2070-2084
Closed Access | Times Cited: 4
Comparative Brain Proteome Analysis of an Indole Alkaloid of Kratom, Mitragynine and Kratom Juice in Rats
Sohaib Jumaah Owaid, Suleiman Yunusa, Lay‐Harn Gam, et al.
(2025)
Closed Access
A case report of reversible ischemic MRI changes and discussion of possible link to kratom use
Danah Bakir, Christian J. Konopka, Sindhu Reddy Pisati, et al.
Neuroimage Reports (2025) Vol. 5, Iss. 2, pp. 100261-100261
Closed Access
Evaluation of Drug Permeability Across Ex vivo Nasal Mucosa: A Simulation-Based Approach to Minimize Thickness-Related Variability
Sheng Zhao, Yongjun Zhao, Jieyu Zuo, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106959-106959
Closed Access
Is Kratom the New ‘Legal High’ on the Block?: The Case of an Emerging Opioid Receptor Agonist with Substance Abuse Potential
George C. Chan ge Chien
Pain Physician (2017) Vol. 1, Iss. 21;1, pp. E195-E198
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top